Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Investment Securities (2016 - 2025)

Alkermes (ALKS) has disclosed Gains from Investment Securities for 16 consecutive years, with $266000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 99.04% to $266000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $31.0 million, a 4.71% increase, with the full-year FY2025 number at $31.0 million, up 4.71% from a year prior.
  • Gains from Investment Securities was $266000.0 for Q4 2025 at Alkermes, down from $27.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $28.3 million in Q1 2024 to a low of -$26.2 million in Q2 2024.
  • A 5-year average of $4.8 million and a median of $655000.0 in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: tumbled 7507.32% in 2021, then soared 13459.71% in 2025.
  • Alkermes' Gains from Investment Securities stood at -$11.0 million in 2021, then plummeted by 32.96% to -$14.6 million in 2022, then soared by 116.39% to $2.4 million in 2023, then soared by 1057.35% to $27.7 million in 2024, then crashed by 99.04% to $266000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Gains from Investment Securities are $266000.0 (Q4 2025), $27.5 million (Q3 2025), and $3.0 million (Q2 2025).